Diagnostic performance of two serological assays for the detection of SARS-CoV-2 specific antibodies: surveillance after vaccination

被引:3
|
作者
Fresco-Taboada, Alba [1 ]
Garcia-Duran, Marga [1 ]
Aira, Cristina [1 ]
Lopez, Lissett [1 ]
Sastre, Patricia [1 ]
van der Hoek, Lia [2 ]
van Gils, Marit J. [2 ]
Brouwer, Philip J. M. [2 ]
Sanders, Rogier W. [2 ]
Holzer, Barbara [3 ]
Zimpernikc, Irene [3 ]
Lopez-Collazo, Eduardo [4 ,5 ,6 ,7 ]
Munoz, Patricia [8 ]
Rueda, Paloma [1 ]
Vela, Carmen [1 ]
机构
[1] Eurofins Ingenasa, Madrid, Spain
[2] Amsterdam UMC, Amsterdam Inst Infect & Immun, Dept Med Microbiol & Infect Prevent, Lab Expt Virol, Amsterdam, Netherlands
[3] Austrian Agcy Hlth & Food Safety, Dept Serol & Virol, Modling, Austria
[4] La Paz Univ Hosp, Innate Immune Response Grp, IdiPAZ, Madrid, Spain
[5] La Paz Univ Hosp, Tummor Immunol Lab, IdiPAZ, Madrid, Spain
[6] La Paz Univ Hosp, Emergency Dept, Madrid, Spain
[7] La Paz Univ Hosp, Emergent Pathol Res Grp, IdiPAZ, Madrid, Spain
[8] Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Clin Microbiol & Infect Dis, Madrid, Spain
关键词
SARS-CoV-2; COVID-19; Vaccination; Serology; RBD; Spike protein;
D O I
10.1016/j.diagmicrobio.2022.115650
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Massive vaccination programs are being carried out to limit the SARS-CoV-2 pandemic that started in December 2019. Serological tests are of major importance as an indicator of circulation of the virus and to assess how vaccine-induced immunity progresses. An Enzyme-Linked Immunosorbent Assay (ELISA) and a Lateral Flow Assay (LFA) have been developed based on the SARS-CoV-2 recombinant Receptor Binding Domain (RBD) and the combination of Spike and Nucleoprotein, respectively. The validation with 1272 serum samples by comparison with INgezim COVID 19 DR showed good diagnostic performance (sensitivity: 93.2%-97.2%; specificity: 98.3%-99.3%) for detection of previous contact with SARS-CoV-2. Moreover, according to our results, these assays can help in the serosurveillance during and after vaccination, by detecting the humoral immune response as soon as 15 days post vaccination and identifying low-respondents. Hence, these tests could play a key role in the progression to a COVID-19 free world, helping to adjust future vaccination protocols. (C) 2022 Elsevier Inc. All rights reserved.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Diagnostic Performance of Serological Assays in the Detection of SARS-CoV-2: A Review
    Carinci, Francesco
    Moreo, Giulia
    Limongelli, Luisa
    Testori, Tiziano
    Lauritano, Dorina
    [J]. APPLIED SCIENCES-BASEL, 2020, 10 (13):
  • [2] Comparison of Serological Assays for the Detection of SARS-CoV-2 Antibodies
    James, Joe
    Rhodes, Shelley
    Ross, Craig S.
    Skinner, Paul
    Smith, Samuel P.
    Shipley, Rebecca
    Warren, Caroline J.
    Goharriz, Hooman
    McElhinney, Lorraine M.
    Temperton, Nigel
    Wright, Edward
    Fooks, Anthony R.
    Clark, Tristan W.
    Brookes, Sharon M.
    Brown, Ian H.
    Banyard, Ashley C.
    [J]. VIRUSES-BASEL, 2021, 13 (04):
  • [3] Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies
    Ainhoa Gutiérrez-Cobos
    Sara Gómez de Frutos
    Diego Domingo García
    Eva Navarro Lara
    Ayla Yarci Carrión
    Leticia Fontán García-Rodrigo
    Arturo Manuel Fraile Torres
    Laura Cardeñoso Domingo
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 955 - 961
  • [4] Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies
    Gutierrez-Cobos, Ainhoa
    Gomez de Frutos, Sara
    Domingo Garcia, Diego
    Navarro Lara, Eva
    Yarci Carrion, Ayla
    Fontan Garcia-Rodrigo, Leticia
    Fraile Torres, Arturo Manuel
    Cardenoso Domingo, Laura
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (05) : 955 - 961
  • [5] Surveillance of Immunological Status after Vaccination by two Serological Assays based on SARS-CoV-2 Spike Protein
    Fresco-Taboada, A.
    Garcia-Duran, M.
    Aira, C.
    Lopez, L.
    Sastre, P.
    Van der Hoek, L.
    Van Gils, M.
    Brouwer, P. J. M.
    Sanders, R. W.
    Holzer, B.
    Zimpernik, I.
    Lopez-Collazo, E.
    Munoz, P.
    Rueda, P.
    Vela, C.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 116 : S40 - S41
  • [6] Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 Antibodies
    Hashem, Anwar M.
    Alhabbab, Rowa Y.
    Algaissi, Abdullah
    Alfaleh, Mohamed A.
    Hala, Sharif
    Abujamel, Turki S.
    Elassouli, M-Zaki
    AL-Somali, Afrah A.
    Alofi, Fadwa S.
    Khogeer, Asim A.
    Alkayyal, Almohanad A.
    Mahmoud, Ahmad Bakur
    Almontashiri, Naif A. M.
    Pain, Arnab
    [J]. PATHOGENS, 2020, 9 (12): : 1 - 10
  • [7] Comparison of Five Serological Assays for the Detection of SARS-CoV-2 Antibodies
    Doerschug, Anja
    Schwanbeck, Julian
    Hahn, Andreas
    Hillebrecht, Anke
    Blaschke, Sabine
    Mese, Kemal
    Gross, Uwe
    Dierks, Sascha
    Frickmann, Hagen
    Zautner, Andreas E.
    [J]. DIAGNOSTICS, 2021, 11 (01)
  • [8] Monitoring of SARS-CoV-2 Specific Antibodies after Vaccination
    Guiomar, Raquel
    Santos, Ana Joao
    Melo, Aryse Martins
    Costa, Ines
    Matos, Rita
    Rodrigues, Ana Paula
    Kislaya, Irina
    Silva, Anabela Santos
    Roque, Carla
    Nunes, Carla
    Aguiar, Joaquim
    Graca, Fatima
    Silva Graca, Antonio
    Machado, Ausenda
    [J]. VACCINES, 2022, 10 (02)
  • [9] Serological Tests in the Detection of SARS-CoV-2 Antibodies
    Guevara-Hoyer, Kissy
    Fuentes-Antras, Jesus
    De la Fuente-Munoz, Eduardo
    Rodriguez de la Pena, Antonia
    Vinuela, Marcos
    Cabello-Clotet, Noemi
    Estrada, Vicente
    Culebras, Esther
    Delgado-Iribarren, Alberto
    Martinez-Novillo, Mercedes
    Jose Torrejon, Maria
    Perez de Diego, Rebeca
    Fernandez-Arquero, Miguel
    Ocana, Alberto
    Perez-Segura, Pedro
    Sanchez-Ramon, Silvia
    [J]. DIAGNOSTICS, 2021, 11 (04)
  • [10] Rapid Serological Tests for SARS-CoV-2: Diagnostic Performance of 4 Commercial Assays
    de Almeida, Sergio M.
    Spalanzani, Regiane N.
    Nogueira, Meri B.
    Sanada, Beatriz
    Cavalli, Barbara M.
    Rotta, Indianara
    Takahashi, Gislene R. A.
    Pereira, Luciane A.
    Moreira, Francielli B.
    Dino, Carolina L. T.
    Graf, Maria E.
    de Almeida, Bernardo M. M.
    Domino, Natalia R.
    Genelhoud, Gustavo
    Bochnia-Bueno, Lucas
    Raboni, Sonia M.
    [J]. MEDICAL PRINCIPLES AND PRACTICE, 2021, 30 (04) : 385 - 394